AwesomeCapital
Search This Blog
Wednesday, July 15, 2026
Conexeu Sciences targets predicate-based 510(k) submission for CXU in Q1 2027
Conexeu Sciences targets predicate-based 510(k) submission for CXU in Q1 2027 after 12‑month P.R.O.O.F. preclinical study
Conexeu Sciences
details
CXU’s
large-volume body contouring and medical aesthetics strategy for its planned regulatory pathway
https://finviz.com/stock?t=CNXU&p=d
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.